Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin de Visser

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cell Reports. Medicine|November 19, 2025
Q&A with Karin de VisserKarin de Visser
Journal for Immunotherapy of Cancer|August 3, 2021
HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trialNoor Alida Maria Bakker, Jossie Rotman, Marc van Beurden, et al.
Cancer Research|June 19, 2021
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer TumorigenesisAnni Laine, Srikar G Nagelli, Caroline Farrington, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cell Reports. Medicine|November 19, 2025
Q&A with Karin de VisserKarin de Visser
Journal for Immunotherapy of Cancer|August 3, 2021
HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trialNoor Alida Maria Bakker, Jossie Rotman, Marc van Beurden, et al.
Cancer Research|June 19, 2021
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer TumorigenesisAnni Laine, Srikar G Nagelli, Caroline Farrington, et al.
Pageof 1